Name : S Rohit Saran (25Y/M)

Date : 06 Nov 2024

Test Asked : Aarogyam C Pro Including Crm Advanced With Utsh, Esr

Report Status: Complete Report

PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF
THYROCARE LAB BAGALUR ROAD HOSUR -
TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH 635109
UTSH,ESR

Report Availability Summary

Note: Please refer to the table below for status of your tests.

16 Ready 0 Ready with Cancellation 0 Processing 0 Cancelled in Lab

TEST DETAILS REPORT STATUS

AAROGYAM C PRO INCLUDING CRM ADVANCED WITH UTSH Ready

CHLORIDE Ready

HOMOCYSTEINE Ready

HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) Ready

Lipoprotein (a) [Lp(a)] Ready

SODIUM Ready

TESTOSTERONE Ready

HBA PROFILE Ready

HEMOGRAM - 6 PART (DIFF) Ready

LIVER FUNCTION TESTS Ready

IRON DEFICIENCY PROFILE Ready

KIDPRO Ready

LIPID PROFILE Ready

T3-T4-USTSH Ready

VITAMIN D TOTAL AND B12 COMBO Ready

APOLIPROTEIN RATIO Ready

ERYTHROCYTE SEDIMENTATION RATE (ESR) Ready

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF THYROCARE LAB BAGALUR ROAD HOSUR - 635109
TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH
UTSH,ESR

Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
APOLIPOPROTEIN - B (APO-B) 51 mg/dL 56 - 145
HOMOCYSTEINE 41.06 µmol/L <15
LIPID
LDL / HDL RATIO 1 Ratio 1.5-3.5
TC/ HDL CHOLESTEROL RATIO 2.3 Ratio 3-5
LIVER
BILIRUBIN (INDIRECT) 1.4 mg/dL 0-0.9
BILIRUBIN - TOTAL 1.73 mg/dL 0.3-1.2
BILIRUBIN -DIRECT 0.33 mg/dL < 0.3

Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY THYROCARE LAB BAGALUR ROAD HOSUR -
: SELF
635109
TEST ASKED : ESR,HBA PROFILE,HEMOGRAM

PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 4.9 %
Bio. Ref. Interval. :

Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics

Below 5.7% : Normal Below 6.5% : Good Control

5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control

Method : Fully Automated H.P.L.C method

AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 94 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control

Method : Derived from HBA1c values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 15:25

Report Released on (RRT) : 06 Nov 2024 17:32
Sample Type : EDTA Whole Blood
Labcode : 0611042364/TN030 Dr Ishant Anand MD(Path)
Barcode : DB286790
Page : 1 of 17
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159, Bangalore

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF THYROCARE LAB BAGALUR ROAD HOSUR - 635109

TEST ASKED : ESR,HBA PROFILE,HEMOGRAM

PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS
ERYTHROCYTE SEDIMENTATION RATE (ESR) MODIFIED WESTERGREN 10 mm / hr
Bio. Ref. Interval. :-

Male : 0-15
Female : 0-20

Please correlate with clinical conditions.

Method:- MODIFIED WESTERGREN

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 15:25
Report Released on (RRT) : 06 Nov 2024 17:32
Sample Type : EDTA Whole Blood
Dr Ishant Anand MD(Path)
Labcode : 0611042364/TN030
Barcode : DB286790 Page : 2 of 17
PROCESSED AT :
Thyrocare
1st Floor, 889 HSR layout
Sector-7 (BDA), No 1159,
Bangalore

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF THYROCARE LAB BAGALUR ROAD HOSUR - 635109

TEST ASKED : ESR,HBA PROFILE,HEMOGRAM

PATIENTID : SS25076561

TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.

HEMOGLOBIN SLS-Hemoglobin Method 15.7 g/dL 13.0-17.0
Hematocrit (PCV) CPH Detection 49.1 % 40.0-50.0
Total RBC HF & EI 5.26 X 10^6/µL 4.5-5.5
Mean Corpuscular Volume (MCV) Calculated 93.3 fL 83.0-101.0
Mean Corpuscular Hemoglobin (MCH) Calculated 29.8 pq 27.0-32.0
Mean Corp.Hemo. Conc (MCHC) Calculated 32 g/dL 31.5-34.5
Red Cell Distribution Width - SD (RDW-SD) Calculated 42.5 fL 39-46
Red Cell Distribution Width (RDW - CV) Calculated 12.4 % 11.6-14
RED CELL DISTRIBUTION WIDTH INDEX (RDWI) Calculated 219.9 - *Refer Note below
MENTZER INDEX Calculated 17.7 - *Refer Note below
TOTAL LEUCOCYTE COUNT (WBC) HF & FC 7.52 X 10³ / µL 4.0 - 10.0
DIFFERENTIAL LEUCOCYTE COUNT
Neutrophils Percentage Flow Cytometry 54.8 % 40-80
Lymphocytes Percentage Flow Cytometry 31.1 % 20-40
Monocytes Percentage Flow Cytometry 9.6 % 2-10
Eosinophils Percentage Flow Cytometry 4.3 % 1-6
Basophils Percentage Flow Cytometry 0.4 % 0-2
Immature Granulocyte Percentage (IG%) Flow Cytometry 0.3 % 0-0.5
Nucleated Red Blood Cells % Flow Cytometry 0.01 % 0.0-5.0
ABSOLUTE LEUCOCYTE COUNT
Neutrophils - Absolute Count Calculated 4.12 X 10³ / µL 2.0-7.0
Lymphocytes - Absolute Count Calculated 2.34 X 10³ / µL 1.0-3.0
Monocytes - Absolute Count Calculated 0.72 X 10³ / µL 0.2 - 1.0
Basophils - Absolute Count Calculated 0.03 X 10³ / µL 0.02 - 0.1
Eosinophils - Absolute Count Calculated 0.32 X 10³ / µL 0.02 - 0.5
Immature Granulocytes (IG) Calculated 0.02 X 10³ / µL 0-0.3
Nucleated Red Blood Cells Calculated 0.01 X 10³ / µL 0.0-0.5
PLATELET COUNT HF & EI 298 X 10³ / µL 150-410
Mean Platelet Volume (MPV) Calculated 10.3 fL 6.5-12
Platelet Distribution Width (PDW) Calculated 10.6 fL 9.6-15.2
Platelet to Large Cell Ratio (PLCR) Calculated 25.7 % 19.7-42.4
Plateletcrit (PCT) Calculated 0.31 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.

*Note - Mentzer index (MI), RDW-CV and RDWI are hematological indices to differentiate between Iron Deficiency Anemia (IDA) and Beta
Thalassemia Trait (BTT). MI >13, RDWI >220 and RDW-CV >14 more likely to be IDA. MI <13, RDWI <220, and RDW-CV <14 more likely
to be BTT. Suggested Clinical correlation. BTT to be confirmed with HB electrophoresis if clinically indicated.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 15:25
Report Released on (RRT) : 06 Nov 2024 17:32
Sample Type : EDTA Whole Blood
Labcode : 0611042364/TN030 Dr Ishant Anand MD(Path)
Barcode : DB286790 Page : 3 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF THYROCARE LAB BAGALUR ROAD HOSUR - 635109

TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED

WITH UTSH

PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS
HOMOCYSTEINE PHOTOMETRY 41.06 µmol/L
Bio. Ref. Interval. :-

Normal Levels : <15 µmol/L

Mild Hyperhomocysteinemia : 15-30 µmol/L
Moderate Hyperhomocysteinemia : 30-100 µmol/L
Severe Hyperhomocysteinemia : >100 µmol/L

Clinical Significance:
Homocysteine is linked to increased risk of premature coronary artery disease, stroke and thromboembolism. Moreover,
alzheimers disease, osteoporosis, venous thrombosis, schizophrenia, cognitive deficiency and pregnancy complications also
elevates Homocysteine levels. The results should be interpreted in conjunction with clinical history and other findings.

High Values:
Elevated homocysteine levels might be due to increasing age, genetic traits, drugs, renal dysfunction and dietary deficiency of
vitamins or smoking. To lower your homocysteine, eat more green vegetables, stop smoking, alcohol. Folic acid helps lowering
elevated levels.

Specifications:
Kit Validation Reference:
Eikelboom JW, et al Ann Intern Med 131 : 363-75 (1999)
https://www.healthline.com/health/homocysteine-levels

Please correlate with clinical conditions.

Method:- SMALL MOLECULE CAPTURE TECHNOLOGY (SMT)

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0611093673/TN030
Barcode : CZ483888 Page : 4 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY THYROCARE LAB BAGALUR ROAD HOSUR -
: SELF
635109
TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH
UTSH
PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS

25-OH VITAMIN D (TOTAL) E.C.L.I.A 31.6 ng/mL

Bio. Ref. Interval. :
Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml

Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical for building
bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.

Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%

Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.

Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

VITAMIN B-12 E.C.L.I.A 414 pg/mL
Bio. Ref. Interval. :
Normal: 197-771 pg/ml

Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs and milk. It
is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath. Vitamin-B12 is used to find
out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For diagnostic purpose, results should always be
assessed in conjunction with the patients medical history, clinical examination and other findings.

Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %

Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431

Method : Fully Automated Electrochemiluminescence Compititive Immunoassay

Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22

Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Labcode : 0611093673/TN030 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CZ483888
Page : 5 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY THYROCARE LAB BAGALUR ROAD HOSUR -
: SELF
635109
TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH
UTSH
PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS

APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 126 mg/dL

Bio. Ref. Interval. :
Male : 86 - 152
Female : 94 - 162

Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 51 mg/dL
Bio. Ref. Interval. :
Male : 56 - 145
Female : 53 - 138

Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER

APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.4 Ratio
Bio. Ref. Interval. :
Male : 0.40 - 1.26
Female : 0.38 - 1.14

Method : Derived from serum Apo A1 and Apo B values

Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22

Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Labcode : 0611093673/TN030 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CZ483888
Page : 6 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF THYROCARE LAB BAGALUR ROAD HOSUR - 635109

TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED

WITH UTSH

PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 0.5 mg/L
Bio. Ref. Interval. :-

< 1.00 - Low Risk

1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation

Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.

Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.

Kit Validation Reference:

1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.

Please correlate with clinical conditions.

Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0611093673/TN030
Barcode : CZ483888 Page : 7 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF THYROCARE LAB BAGALUR ROAD HOSUR - 635109

TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED

WITH UTSH

PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS
LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 16.3 mg/dL
Bio. Ref. Interval. :-

Adults : < 30.0 mg/dl

Clinical Significance:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.

Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %

Kit Validation Reference:

Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444

Please correlate with clinical conditions.

Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0611093673/TN030
Barcode : CZ483888 Page : 8 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF THYROCARE LAB BAGALUR ROAD HOSUR - 635109

TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED

WITH UTSH

PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS
TESTOSTERONE E.C.L.I.A 521 ng/dL
Bio. Ref. Interval. :-

280 - 800

Clinical Significance: Clinical evaluation of serum testosterone, along with serum LH, assists in evaluation of Hypogonadal males.
Major causes of lowered testosterone in males include Hypogonadotropic hypogonadism, testicular failure Hyperprolactinema,
Hypopituitarism some types of liver and kidney diseases and critical illness.

Specifications: Precision: Intra assay (%CV): 11.50 %, Inter assay (%CV): 5.70%; Sensitivity: 7 ng/dL.
Kit Validation Reference: Wilson JD Foster DW (Eds) Williams Textbook of Endocrinology 8th Edition WB Saunders Piladelphia
Pennsylvania.

Note : The Biological Reference Range mentioned is specific to the age group and gender. Kindly correlate clinically.

Please correlate with clinical conditions.

Method:- Fully Automated Electrochemiluminescence Compititive Immunoassay

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0611093673/TN030
Barcode : CZ483888 Page : 9 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY THYROCARE LAB BAGALUR ROAD HOSUR -
: SELF
635109
TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH
UTSH
PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS

IRON PHOTOMETRY 118.5 µg/dL

Bio. Ref. Interval. :
Male : 65 - 175
Female : 50 - 170

Method : Ferrozine method without deproteinization

TOTAL IRON BINDING CAPACITY (TIBC) PHOTOMETRY 430.81 µg/dL
Bio. Ref. Interval. :
Male: 225 - 535 µg/dl Female: 215 - 535 µg/dl

Method : Spectrophotometric Assay

% TRANSFERRIN SATURATION CALCULATED 27.51 %
Bio. Ref. Interval. :
13 - 45

Method : Derived from IRON and TIBC values

UNSAT.IRON-BINDING CAPACITY(UIBC) PHOTOMETRY 312.31 µg/dL
Bio. Ref. Interval. :
162 - 368

Method : SPECTROPHOTOMETRIC ASSAY

Please correlate with clinical conditions.

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22

Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Labcode : 0611093673/TN030 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CZ483888
Page : 10 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY THYROCARE LAB BAGALUR ROAD HOSUR - 635109
: SELF
TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH
UTSH
PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL CHOLESTEROL PHOTOMETRY 119 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 52 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 53 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 79 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 2.3 Ratio 3-5
TRIG / HDL RATIO CALCULATED 1.53 Ratio < 3.12
LDL / HDL RATIO CALCULATED 1 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.97 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 66.71 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 15.84 mg/dL 5 - 40
Please correlate with clinical conditions.

Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)

DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150

BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
HIGH >240 BORDERLINE HIGH 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Labcode : 0611093673/TN030 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CZ483888 Page : 11 of 17

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY THYROCARE LAB BAGALUR ROAD HOSUR - 635109
: SELF
TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH
UTSH
PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
ALKALINE PHOSPHATASE PHOTOMETRY 81.58 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 1.73 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.33 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 1.4 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 17.5 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 23.8 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 25 U/L < 45
SGOT / SGPT RATIO CALCULATED 0.95 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.45 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.57 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.88 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.59 Ratio 0.9 - 2
Please correlate with clinical conditions.

Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Labcode : 0611093673/TN030 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CZ483888 Page : 12 of 17

PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY THYROCARE LAB BAGALUR ROAD HOSUR - 635109
: SELF
TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH
UTSH
PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 9.33 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 0.72 mg/dL 0.72-1.18
BUN / SR.CREATININE RATIO CALCULATED 12.96 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 19.97 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 27.73 Ratio < 52
CALCIUM PHOTOMETRY 9.66 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 5.62 mg/dL 4.2 - 7.3
SODIUM I.S.E 140.42 mmol/L 136 - 145
CHLORIDE I.S.E 104.55 mmol/L 98 - 107
Please correlate with clinical conditions.

Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method
SOD - ION SELECTIVE ELECTRODE
CHL - ION SELECTIVE ELECTRODE

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Labcode : 0611093673/TN030 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)

Barcode : CZ483888 Page : 13 of 17

 PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

THYROCARE LAB BAGALUR ROAD HOSUR - 635109
REF. BY : SELF

TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED WITH

UTSH

PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 155 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 8.47 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 1.73 µIU/mL 0.54-5.30

Comments : SUGGESTING THYRONORMALCY

The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :

T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay

USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay

Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Labcode : 0611093673/TN030 Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Barcode : CZ483888 Page : 14 of 17
PROCESSED AT :
Thyrocare,
5CA-711, 3rd Floor,
HRBR 2nd Block,
Hennur, Bengaluru-560043

NAME : S ROHIT SARAN (25Y/M) HOME COLLECTION :

REF. BY : SELF THYROCARE LAB BAGALUR ROAD HOSUR - 635109

TEST ASKED : AAROGYAM C PRO INCLUDING CRM ADVANCED

WITH UTSH

PATIENTID : SS25076561
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 130 mL/min/1.73 m2
Bio. Ref. Interval. :-

> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease

Clinical Significance

The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.

Reference

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.

Please correlate with clinical conditions.

Method:- CKD-EPI Creatinine Equation

~~ End of report ~~

Sample Collected on (SCT) : 06 Nov 2024 11:00

Sample Received on (SRT) : 06 Nov 2024 17:22
Report Released on (RRT) : 06 Nov 2024 21:00
Sample Type : SERUM
Dr Syeda Sumaiya MD(Path) Dr.Ashwin Mathew MD(Path)
Labcode : 0611093673/TN030
Barcode : CZ483888 Page : 15 of 17
 CUSTOMER DETAILS

As declared in our data base

Name: S ROHIT SARAN Age: 25Y Sex: M

Barcodes/Sample_Type : DB286790 (EDTA),CZ483888 (SERUM)

Labcode : 0611042364,0611093673
Ref By : SELF
Sample_Type/Tests : EDTA:HBA PROFILE , HEMOGRAM - 6 PART (DIFF) , ESR
SERUM:AAROGYAM C PRO INCLUDING CRM ADVANCED WITH UTSH
Sample Collected At : THYROCARE LAB BAGALUR ROAD HOSUR - 635109

Sample Collected on (SCT) : 06 Nov 2024 11:00

Report Released on (RRT) : 06 Nov 2024 21:00
Amount Collected : Rs.2000/-(two thousand only)

Thyrocare,D-37/1,MIDC,Turbhe,Navi Mumbai - 400703. | Phone:022 - 6712 3400 |www.thyrocare.com | [email protected]

Page : 16 of 17
 CONDITIONS OF REPORTING

v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00

EXPLANATIONS

v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.

SUGGESTIONS

v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at [email protected] or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333

+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)

Page : 17 of 17